Overview

Methoxyflurane for Analgesia During Hysteroscopy

Status:
NOT_YET_RECRUITING
Trial end date:
2026-01-30
Target enrollment:
Participant gender:
Summary
This study is to assess the non-inferiority of using inhaled methoxyflurane (MOF) versus intravenous conscious sedation with fentanyl and midazolam on women's perception of pain, during hysteroscopy and/or polypectomy in an outpatient setting. The researchers will determine whether the participants receiving the inhaled MOF (experimental group) achieve similar clinical effects in reduction of pain and ability to complete the procedure. Women's perception of pain will be recorded on a scale from 0 to 10 using the numeric rating scale (NRS).
Phase:
NA
Details
Lead Sponsor:
Dr. John A. Thiel Medical Professional Corporation
Treatments:
Analgesia
Anesthetics, Inhalation
Methoxyflurane